Auransa Inc.

États‑Unis d’Amérique

 
Quantité totale PI 18
Rang # Quantité totale PI 84 156
Note d'activité PI 2/5.0    13
Rang # Activité PI 67 688
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

9 1
2 0
6 0
0
 
Dernier brevet 2024 - Pentamidine analogue polymorphs,...
Premier brevet 2017 - Pharmaceutical compositions and ...
Dernière marque 2019 - AURANSA
Première marque 2019 - AURANSA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Pentamidine analogue polymorphs, formulations, and methods thereof. The present invention relates...
2021 Invention Analogues of pentamidine and methods for treating infections. The present disclosure provides a ...
Invention Analogues of pentamidine and methods for treating infections. The present disclosure provides a g...
Invention Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity. This ...
2020 Invention Derivatives of piperlongumine and uses thereof. The present invention relates to a group of 1-[(...
2019 Invention Genomics-based identification and characterization of rare cell types. This disclosure provides g...
Invention Analogues of pentamidine and uses therefor. The present disclosure provides a group of aromatic ...
Invention Analogues of pentamidine and uses therefor. The present disclosure provides a group of aromatic (...
P/S Consulting services in the fields of biotechnology, pharmaceutical research and development, labo...
Invention Methods for treating a subtype of small cell lung cancer. This disclosure provides methods for t...
Invention Methods for treating a subtype of small cell lung cancer. This disclosure provides methods for tr...
2018 Invention Derivatives of piperlongumine and uses thereof. The present invention relates to a group of 1-[(E...
Invention Derivatives of piperlongumine and uses thereof. EE)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-2,3- ...